BioSpring GmbH
Frankfurt, Germany
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (3)
○ EMA GMP
○ MHRA GMP
Quick Facts: BioSpring GmbH
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Frankfurt, Germany
- Modalities
- Oligonucleotide, mRNA, siRNA, ASO, gRNA, Nucleic Acid API
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About BioSpring GmbH
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesOligonucleotide, mRNA, siRNA, ASO, gRNA, Nucleic Acid API
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (6 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press3 articles
Broad modality coverage (6 modalities)
Recent News 3 articles
BioSpring announces €100+m investment in new synthetic nucleic acid facility - European Biotechnology Magazine
Nucleic Acid Therapeutics CDMO Market Size, Share & Growth Graph by 2034 - Straits Research
BioSpring and Pantherna agree on strategic cooperation in the field of genome editing - Drug Discovery News
Frequently Asked Questions About BioSpring GmbH
What is BioSpring GmbH's CDMO Signal Score?
BioSpring GmbH has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating BioSpring GmbH for a manufacturing program?
Use the free AI matchmaker to compare BioSpring GmbH against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 82.5
mRNA, Oligonucleotide, Biologics
Nitto Denko Avecia
Milford, MA
Signal Score: 80.3
Oligonucleotide, mRNA
Kaneka Eurogentec
Seraing, BE
Signal Score: 80.3
mRNA, Plasmid, Oligonucleotide
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Signal Score: 79.4
mRNA, Oligonucleotide, Biologics
ST Pharm
Seoul, KR
Signal Score: 72.8
Oligonucleotide, mRNA